• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌幸存者绝经后症状管理的近期综述

A Recent Review of the Management of Postmenopausal Symptoms in Breast Cancer Survivors.

作者信息

Kim Chaewon, Na Yoojin, Lee Sanghee, Park Jung Yoon, Chung Youn-Jee, Song Jaeyen, Kim Mee-Ran

机构信息

Division of Reproductive Endocrinology, Department of Obstetrics and Gynecology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

出版信息

J Menopausal Med. 2023 Dec;29(3):85-91. doi: 10.6118/jmm.23016.

DOI:10.6118/jmm.23016
PMID:38230591
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10796204/
Abstract

The treatment strategy for postmenopausal symptoms resulting from estrogen deficiency in breast cancer survivors receiving endocrine therapy should differ from that in normal women. Several nonhormonal pharmacological therapies can be used to treat vasomotor symptoms. Cognitive-behavioral therapy can help alleviate psychophysiological symptoms, including depression and sleep disorders. Topical vaginal estrogen and moisturizers may aid in treating genitourinary symptoms. Additionally, chronic conditions must be individually managed. Prevention of osteoporosis should always be included in the management, and physicians should be alert to possible cardiovascular risk and cognitive function changes.

摘要

接受内分泌治疗的乳腺癌幸存者因雌激素缺乏导致的绝经后症状的治疗策略应与正常女性不同。几种非激素药物疗法可用于治疗血管舒缩症状。认知行为疗法有助于缓解心理生理症状,包括抑郁和睡眠障碍。局部阴道雌激素和保湿剂可能有助于治疗泌尿生殖系统症状。此外,慢性病必须进行个体化管理。骨质疏松症的预防应始终纳入管理之中,医生应警惕可能的心血管风险和认知功能变化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5f4/10796204/81469a0e7fa9/jmm-29-85-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5f4/10796204/81469a0e7fa9/jmm-29-85-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5f4/10796204/81469a0e7fa9/jmm-29-85-g001.jpg

相似文献

1
A Recent Review of the Management of Postmenopausal Symptoms in Breast Cancer Survivors.乳腺癌幸存者绝经后症状管理的近期综述
J Menopausal Med. 2023 Dec;29(3):85-91. doi: 10.6118/jmm.23016.
2
Estrogen deficiency symptom management in breast cancer survivors in the changing context of menopausal hormone therapy.在绝经激素治疗环境不断变化的情况下,乳腺癌幸存者雌激素缺乏症状的管理
Semin Oncol. 2003 Dec;30(6):776-88. doi: 10.1053/j.seminoncol.2003.08.021.
3
Management of postmenopausal women: Collège National des Gynécologues et Obstétriciens Français (CNGOF) and Groupe d'Etude sur la Ménopause et le Vieillissement (GEMVi) Clinical Practice Guidelines.绝经后女性管理:法国妇产科学院(CNGOF)和绝经与衰老研究小组(GEMVi)临床实践指南。
Maturitas. 2022 Sep;163:62-81. doi: 10.1016/j.maturitas.2022.05.008. Epub 2022 Jun 9.
4
Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society.绝经后妇女阴道和外阴萎缩的管理:北美绝经学会 2013 年立场声明。
Menopause. 2013 Sep;20(9):888-902; quiz 903-4. doi: 10.1097/GME.0b013e3182a122c2.
5
Managing Menopausal Symptoms and Associated Clinical Issues in Breast Cancer Survivors.管理乳腺癌幸存者的更年期症状及相关临床问题。
J Clin Endocrinol Metab. 2017 Oct 1;102(10):3647-3661. doi: 10.1210/jc.2017-01138.
6
Prognostic features of menopausal and postmenopausal applicants for life insurance.更年期及绝经后寿险申请人的预后特征。
J Insur Med. 1996;28(1):27-34.
7
The menopause: benefits and risks of estrogen-progestogen replacement therapy.更年期:雌激素 - 孕激素替代疗法的益处与风险
Fertil Steril. 1982 Apr;37(4):457-74. doi: 10.1016/s0015-0282(16)46149-2.
8
Tissue-selective estrogen complexes for postmenopausal women.用于绝经后妇女的组织选择性雌激素复合物。
Maturitas. 2013 Nov;76(3):213-20. doi: 10.1016/j.maturitas.2013.06.003. Epub 2013 Jul 11.
9
A systematic review of randomised clinical trials - The safety of vaginal hormones and selective estrogen receptor modulators for the treatment of genitourinary menopausal symptoms in breast cancer survivors.一项随机临床试验的系统评价——阴道激素和选择性雌激素受体调节剂治疗乳腺癌幸存者泌尿生殖系统绝经症状的安全性。
Post Reprod Health. 2023 Dec;29(4):222-231. doi: 10.1177/20533691231208473. Epub 2023 Oct 16.
10
Management of genitourinary syndrome of menopause in female cancer patients: a focus on vaginal hormonal therapy.女性癌症患者泌尿生殖系统绝经综合征的管理:关注阴道激素治疗。
Am J Obstet Gynecol. 2020 Feb;222(2):103-113. doi: 10.1016/j.ajog.2019.08.043. Epub 2019 Aug 29.

引用本文的文献

1
Effects of exercise interventions on bone health and body composition in postmenopausal women with breast cancer: a systematic review and meta-analysis.运动干预对绝经后乳腺癌女性骨骼健康和身体成分的影响:一项系统综述和荟萃分析
Front Oncol. 2025 Jun 18;15:1593165. doi: 10.3389/fonc.2025.1593165. eCollection 2025.

本文引用的文献

1
The 2023 nonhormone therapy position statement of The North American Menopause Society.北美绝经学会 2023 年非激素治疗立场声明。
Menopause. 2023 Jun 1;30(6):573-590. doi: 10.1097/GME.0000000000002200.
2
Hormone Therapy and Risk of Breast Cancer: Where Are We Now?激素疗法与乳腺癌风险:我们目前的状况如何?
J Menopausal Med. 2022 Aug;28(2):47-51. doi: 10.6118/jmm.21035.
3
Risk of Cardiovascular Disease in Women With and Without Breast Cancer: The Pathways Heart Study.有乳腺癌和无乳腺癌女性的心血管疾病风险:Pathways Heart 研究。
J Clin Oncol. 2022 May 20;40(15):1647-1658. doi: 10.1200/JCO.21.01736. Epub 2022 Apr 6.
4
Effects of physical exercise on cognitive function of breast cancer survivors receiving chemotherapy: A systematic review of randomized controlled trials.运动锻炼对接受化疗的乳腺癌幸存者认知功能的影响:一项随机对照试验的系统评价。
Breast. 2022 Jun;63:113-122. doi: 10.1016/j.breast.2022.03.014. Epub 2022 Mar 28.
5
Aromatase inhibitor-associated musculoskeletal pain: An overview of pathophysiology and treatment modalities.芳香化酶抑制剂相关的肌肉骨骼疼痛:病理生理学与治疗方式概述
SAGE Open Med. 2022 Mar 19;10:20503121221078722. doi: 10.1177/20503121221078722. eCollection 2022.
6
Risk of cardiovascular disease in breast cancer patients receiving aromatase inhibitors vs. tamoxifen: A systematic review and meta-analysis.接受芳香化酶抑制剂与他莫昔芬治疗的乳腺癌患者发生心血管疾病的风险:系统评价和荟萃分析。
J Clin Pharm Ther. 2022 May;47(5):575-587. doi: 10.1111/jcpt.13598. Epub 2022 Jan 4.
7
Updated guidance on the management of cancer treatment-induced bone loss (CTIBL) in pre- and postmenopausal women with early-stage breast cancer.早期乳腺癌绝经前和绝经后女性癌症治疗引起的骨质流失(CTIBL)管理的更新指南。
J Bone Oncol. 2021 Mar 18;28:100355. doi: 10.1016/j.jbo.2021.100355. eCollection 2021 Jun.
8
Updates on Therapeutic Alternatives for Genitourinary Syndrome of Menopause: Hormonal and Non-Hormonal Managements.更年期泌尿生殖综合征治疗选择的最新进展:激素及非激素管理
J Menopausal Med. 2021 Apr;27(1):1-7. doi: 10.6118/jmm.20034.
9
The Effect of Exercise on Life Quality and Depression Levels of Breast Cancer Patients.运动对乳腺癌患者生活质量和抑郁水平的影响。
Asian Pac J Cancer Prev. 2021 Mar 1;22(3):725-732. doi: 10.31557/APJCP.2021.22.3.725.
10
Efficacy of cognitive behavioral therapy for insomnia in breast cancer: A meta-analysis.认知行为疗法治疗乳腺癌患者失眠的疗效:一项荟萃分析。
Sleep Med Rev. 2021 Feb;55:101376. doi: 10.1016/j.smrv.2020.101376. Epub 2020 Sep 7.